Brinker Capital Investments’s Johnson & Johnson JNJ Stock Holding History

Brinker Capital Investments’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$55.4M	Sell	226,615 -378	-0.2%	-$88K	0.47%	30
2025 Q4	$47M	Buy	226,993 +15,311	+7%	+$3.03M	0.34%	45
2025 Q3	$39.3M	Sell	211,682 -1,124	-0.5%	-$193K	0.3%	49
2025 Q2	$32.5M	Buy	212,806 +9,037	+4%	+$1.39M	0.28%	62
2025 Q1	$33.8M	Buy	203,769 +4,656	+2%	+$729K	0.33%	48
2024 Q4	$28.8M	Sell	199,113 -2,675	-1%	-$415K	0.29%	59
2024 Q3	$32.7M	Buy	201,788 +5,562	+3%	+$886K	0.33%	50
2024 Q2	$28.7M	Sell	196,226 -2,660	-1%	-$396K	0.3%	54
2024 Q1	$31.5M	Sell	198,886 -1,030	-0.5%	-$164K	0.34%	48
2023 Q4	$32.3M	Sell	199,916 -19,931	-9%	-$3.06M	0.38%	48
2023 Q3	$34.2M	Sell	219,847 -29,292	-12%	-$4.83M	0.41%	40
2023 Q2	$41.2M	Buy	+249,139	New	+$40.2M	0.44%	33
2023 Q1	–	Sell	-174,260	Closed	-$30.8M	–	1609
2022 Q4	$30.8M	Sell	174,260 -8,588	-5%	-$1.48M	0.61%	24
2022 Q3	$29.9M	Sell	182,848 -5,366	-3%	-$908K	0.62%	26
2022 Q2	$33.4M	Sell	188,214 -22,994	-11%	-$4.1M	0.63%	26
2022 Q1	$37.4M	Buy	211,208 +2,903	+1%	+$494K	0.58%	30
2021 Q4	$35.6M	Buy	208,305 +23,765	+13%	+$3.89M	0.52%	34
2021 Q3	$30.4M	Sell	184,540 -332	-0.2%	-$56.6K	0.48%	41
2021 Q2	$30.5M	Buy	184,872 +1,660	+0.9%	+$275K	0.4%	49
2021 Q1	$30.1M	Buy	183,212 +44,774	+32%	+$7.24M	0.45%	47
2020 Q4	$21.8M	Sell	138,438 -50,494	-27%	-$7.45M	0.34%	51
2020 Q3	$28.1M	Buy	188,932 +180,717	+2,200%	+$26.7M	0.48%	38
2020 Q2	$1.16M	Buy	+8,215	New	+$1.2M	0.05%	199
2020 Q1	–	Sell	-2,645	Closed	-$386K	–	535
2019 Q4	$386K	Buy	2,645 +1,140	+76%	+$155K	0.01%	279
2019 Q3	$195K	Sell	1,505 -1,561	-51%	-$206K	0.01%	325
2019 Q2	$427K	Buy	3,066 +940	+44%	+$130K	0.01%	312
2019 Q1	$297K	Sell	2,126 -1,934	-48%	-$259K	0.01%	310
2018 Q4	$524K	Sell	4,060 -149	-4%	-$20.8K	0.02%	264
2018 Q3	$582K	Buy	4,209 +194	+5%	+$25.8K	0.02%	232
2018 Q2	$487K	Buy	4,015 +147	+4%	+$18.3K	0.02%	261
2018 Q1	$496K	Buy	3,868 +343	+10%	+$46.4K	0.02%	244
2017 Q4	$492K	Hold	3,525	–	–	0.02%	253
2017 Q3	$458K	Buy	3,525 +88	+3%	+$11.7K	0.02%	237
2017 Q2	$455K	Sell	3,437 -328	-9%	-$41.8K	0.02%	232
2017 Q1	$469K	Buy	3,765 +457	+14%	+$54.6K	0.02%	225
2016 Q4	$381K	Buy	3,308 +98	+3%	+$11.3K	0.02%	226
2016 Q3	$379K	Buy	3,210 +108	+3%	+$13.1K	0.02%	220
2016 Q2	$376K	Sell	3,102 -186	-6%	-$21.1K	0.02%	231
2016 Q1	$356K	Sell	3,288 -758	-19%	-$78.5K	0.02%	234
2015 Q4	$416K	Buy	4,046 +1,164	+40%	+$117K	0.02%	244
2015 Q3	$269K	Buy	2,882 +149	+5%	+$14.4K	0.01%	267
2015 Q2	$266K	Buy	2,733 +2,031	+289%	+$203K	0.01%	254
2015 Q1	$71K	Sell	702 -1,651	-70%	-$168K	﹤0.01%	299
2014 Q4	$246K	Buy	2,353 +1,785	+314%	+$188K	0.01%	249
2014 Q3	$61K	Hold	568	–	–	﹤0.01%	274
2014 Q2	$59K	Sell	568 -300	-35%	-$30.3K	﹤0.01%	283
2014 Q1	$85K	Buy	868 +541	+165%	+$50.2K	﹤0.01%	281
2013 Q4	$30K	Sell	327 -2,057	-86%	-$190K	﹤0.01%	296
2013 Q3	$207K	Buy	2,384 +55	+2%	+$4.93K	0.01%	256
2013 Q2	$200K	Buy	+2,329	New	+$198K	0.01%	257

Other funds holding JNJ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Brinker Capital Investments's JNJ Position: Q1 2026 in Review

Brinker Capital Investments reduced its Johnson & Johnson (JNJ) stake by 0.17% in Q1 2026, selling an estimated $88K and leaving 226,615 shares worth $55.4M. The position accounts for 0.47% of the portfolio, ranked #30.

Brinker Capital Investments first reported a position in JNJ in Q2 2013 and has held it in 50 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

Brinker Capital Investments held 226,615 shares of Johnson & Johnson worth $55.4M as of Q1 2026.
Brinker Capital Investments sold 378 Johnson & Johnson shares in Q1 2026, an estimated $88K.
Johnson & Johnson made up 0.47% of Brinker Capital Investments's portfolio in Q1 2026, its #30 holding.
Brinker Capital Investments first reported a position in Johnson & Johnson in Q2 2013 and has held it in 50 quarters since.
4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Brinker Capital Investments's 13F filing for Q1 2026, filed 13 May 2026.